Not Yet RecruitingPhase 4

Randomized Controlled Study to Compare Efficacy of Aspirin 75mg and 150mg In the Prevention of Preeclampsia In High Risk Pregnant Women

86 participantsStarted 2026-01-15

Plain-language summary

Preeclampsia in pregnancy is a dreaded complication which has both fetal and maternal adverse outcomes. Studies and WHO have advocated that this complication can be prevented by Aspirin. However which dose is more effective in preventing preeclampsia, whether 75mg or 150mg, will be known from this study.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * • All pregnant women with Gestosis score of 3 or more who consents for the study and aged 18 years and above. Exclusion Criteria: * • Known hypersensitivity to aspirin, uncontrolled asthma with NSAID sensitivity * Bleeding disorders, platelet dysfunction, thrombocytopenia, anticoagulant use, active peptic ulcer, history of GI bleed, severe hepatic/ renal disease

What they're measuring

Incidence of Preeclampsia

Timeframe: 1 year (After the time of randomization till delivery)

Trial details

NCT IDNCT07373756

SponsorDr. Sunita Pun

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Pregnancy Induced Hypertension (PIH) trials